Showing 1 to 8 of 8 results
CityUHK has achieved new milestones in research, with 10 outstanding scholars receiving funding from the RGC's Collaborative Research Fund, totaling over HK$60 million—marking a record high for the University.
Three research projects by CityUHK outstanding scholars have been awarded funding under the 2024/25 NSFC and RGC Collaborative Research Scheme, amounting to over HK$8.8 million. The number of funded projects for this exercise at CityUHK was tied for the highest in Hong Kong. Additionally, five CityUHK scholars have been awarded funding from the 2024/25 NSFC/RGC Joint Research Scheme, with total funding exceeding HK$6 million.
Thirty-two outstanding scientists from CityUHK have been awarded funding from the National Nature Science Foundation of China for 2024.
A major advance in treating spinal cord injuries by using genetically modified human neural stem cells has been made by a team co-led by CityU and the University of Hong Kong.
Four academics from CityU have been successful under the Senior Research Fellow Scheme and the Research Fellow Scheme (2023/24) established by RGC.
Researchers at CityU have identified and demonstrated for the first time a therapeutic small molecule, M1, that can restore the visual function in the mammalian central nervous system, offering hope for patients with optic nerve damage such as glaucoma-related vision loss.
Researchers at CityU received tremendous accolades at Inventions Geneva Evaluation Days (IGED) 2022 by winning a total of 22 awards, the highest number among local institutions for two years in a row.
Researchers from CityU won the highest number of awards among all universities in Hong Kong at IGED 2021, including a Gold Medal with Congratulations of the Jury, five Gold Medals, three Silver Medals and three Bronze Medals, demonstrating the excellence of the research carried out at CityU.